Bristol-Myers Squibb Co. (NYSE: BMY) announced during morning trading in the stock market today that it will buy Alpharetta, Ga. based Inhibitex, Inc. (NASDAQ: INHX) for nearly $2.5 billion. Pending approval of the boards of directors of both companies, INHX is up over 140% today and over 500% since our first alert on INHX on
Continue Reading →
9
JAN
0
Share